Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

LabAnswer and OpGen implement the STARLIMS Cloud Platform to Support OpGen’s CLIA Certified Clinical Services Laboratory in Under Four Months

Published: Tuesday, August 13, 2013
Last Updated: Tuesday, August 13, 2013
Bookmark and Share
LabAnswer provides end-to-end service solution for OpGen to support their new clinical laboratory using the latest Laboratory Information Management System (LIMS) cloud platform technology.

LabAnswer has announced the implementation of a cloud based, HIPAA compliant system to support OpGen’s newly launched clinical services laboratory. This CLIA certified laboratory will focus on developing a best-in-class portfolio of genetic tests and analysis services for the surveillance and identification of healthcare associated infections (HAIs) and human pathogens. Next generation DNA and genetic analysis technologies generate a tremendous amount of sequencing data that benefits significantly from automated scientific data management that a LIMS system provides.

OpGen contacted LabAnswer for assistance in implementing a system to support the launch of their new clinical laboratory services. With a requirement to have a system up and running in less than four months, OpGen selected LabAnswer because of its depth and breadth of experience in providing complete end-to-end service solutions with capabilities to take a system’s implementation from strategy and planning, through solution implementation and then ongoing support. LabAnswer brought to bear subject matter experts with hands on experience running labs, superb design and requirements gathering skills, configuration expertise, and project management and execution methodologies to make this a reality.

LabAnswer and OpGen identified the STARLIMS Cloud Platform as the enterprise information system to support the laboratory. The STARLIMS application provides configurable functionality to support business functions required by the clinical lab. Deploying via a cloud platform provides many benefits including no upfront capital or hardware costs, secure infrastructure, data privacy controls, and flexibility needed to rapidly develop and deploy an application. As business demand for the clinical services increases, the cloud platform will also be able to continuously scale without hardware upgrade projects.

At the onset, LabAnswer and OpGen formulated both strategic and tactical plans to deliver highest value functionality within strict business deadlines. In a strategic planning capacity, LabAnswer defined implementation scope by defining vision, goals and objectives, creating business process workflows and eliciting requirements.  After the initial scope was defined, the teams worked together to prioritize critical system and high value functions to be implemented in the LIMS, and relegated lesser value functions to an enhancement queue. In parallel, the STARLIMS Cloud Platform was setup to support the configuration, testing and deployment phases of the project. LabAnswer developed the system in an iterative prototyping model that kept the OpGen team constantly engaged in the evolution of the system.  As the system development entered into the final phase, LabAnswer executed the training and data prep for system go live in July.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

LabAnswer and Kona DataSearch Announce Partnership
Partners will work collaboratively on building and jointly providing customers with integrated solutions.
Wednesday, April 02, 2014
LabAnswer Selects John F. Conway as Director of R & D Strategy
New position will strategize and architect scientific data management systems.
Tuesday, February 25, 2014
LabAnswer Receives Prime Award for CIO-SP3 Contract
LabAnswer is set to Provide Market-Leading Scientific Data Management and Laboratory Informatics Services to Federal Agencies through Government-Wide Acquisition Contract
Tuesday, July 31, 2012
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!